Post-Operative Prostate Cancer study: Radiotherapy
Official title Comparing Moderately and Ultra Hypofractionated Radiation Treatments for Post-operative Prostate Cancer
ClinicalTrials.gov ID: NCT06409910
What this study is testing
- What it's testing
- This study tests if a short, intense radiation schedule is as safe and effective as a longer one. It compares two ways of giving radiation after prostate surgery.
- Who it's for
- You may be able to join if you had prostate surgery and are being considered for radiation treatment.
- What's involved
- You would receive radiation shots at a hospital. One group gets 20 sessions of 2.7 Gy each. The other gets 5 sessions of 6 Gy each, plus shots to nearby lymph nodes on alternate days.
- Time commitment
- The treatment lasts about 6 weeks, plus follow‑up visits after treatment.
- Phase 2: a mid-size study of how well it works
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, men only
You may be able to join if
- Age \>/= 18 years
- Able to provide informed consent
- Histologic diagnosis of prostate adenocarcinoma
- ECOG performance status 0-1
- Previous radical prostatectomy \> 6 months prior to radiotherapy start date
You likely can't join if
- Prior pelvic radiotherapy
- Contraindications to radiotherapy
- Confirmed metastases (if scan has been done for clinical care)
- Participants with visible disease in the prostate bed or pelvic lymph nodes on imaging are not eligible for treatment on study.
See the full eligibility criteria
- Age \>/= 18 years
- Able to provide informed consent
- Histologic diagnosis of prostate adenocarcinoma
- ECOG performance status 0-1
- Previous radical prostatectomy \> 6 months prior to radiotherapy start date
- Planned to receive post-operative radiation
- Prior pelvic radiotherapy
- Contraindications to radiotherapy
- Confirmed metastases (if scan has been done for clinical care)
- Participants with visible disease in the prostate bed or pelvic lymph nodes on imaging are not eligible for treatment on study.
The study team makes the final eligibility decision.
Where it is enrolling
- London, Ontario, Canada
- Toronto, Ontario, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling male, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at London, Ontario, Canada; Toronto, Ontario, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.